Zeliha Guler (Amsterdam UMC): Development of a novel wound-healing implant with localized estradiol delivery
One out of four women is under risk for prolapse, and it increases up to 60% by age or giving birth. For the correction of prolapse permanent implants are being used, but they may cause clinical complications in the long term. A newly developed degradable implant can eliminate clinical complications, in combination with the electrospinning technique, provides the natural structures for the cells and tissues to interact with. By addition of estradiol into implants, the healing and regeneration of the pelvic tissues is further improved. The technology may lead to a groundbreaking solution for prolapse treatment and could benefit a large patient population and clinicians.
Ewelina Weglarz-Tomczak (UvA): Novel lysosomal protease inhibitors for the treatment of Alzheimer’s disease Highly specified proteases are the key regulators in the molecular mechanism of neurodegeneration in Alzheimer’s disease. AI-powered technology developed by NatInLab has led to the discovery of how those proteases are controlled in the human organism. Based on this knowledge, developing novel, […]
Georges Janssens (Amsterdam UMC): MyHeBu (My Health Buddy), a wearable device-based and AI-powered digital twin to track your health and aging. Many people are tracking all of their health data using wearable devices, but it’s not really giving them answers to simple questions like: ‘How often should I exercise?’, or ‘Is my high protein diet […]
Job Calis (Amsterdam UMC) and Mark Hoogendoorn (VU): IMPALA: Innovative Monitoring system for PAediatrics in Low-resource settings: an Aid to save lives. Each year, more than 3 million children die in poor countries. At least half of these deaths can be prevented by early recognition, before patients deteriorate. In Europe, patient monitors are used to […]